MYELODYSPLASTIC SYNDROMES
Clinical trials for MYELODYSPLASTIC SYNDROMES explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASTIC SYNDROMES trials appear
Sign up with your email to follow new studies for MYELODYSPLASTIC SYNDROMES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug may help MDS patients ditch blood transfusions
Disease control Not yet recruitingThis study tests an experimental drug called TAK-226 in about 27 Japanese adults with a bone marrow condition called myelodysplastic syndromes (MDS) who need regular blood transfusions. The goal is to see if TAK-226 can help them go without transfusions for at least 8 weeks. Part…
Matched conditions: MYELODYSPLASTIC SYNDROMES
Phase: PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated May 17, 2026 03:19 UTC
-
New drug combo targets Tough-to-Treat bone marrow cancer
Disease control Not yet recruitingThis study tests a combination of two drugs, pacritinib and azacitidine, in 25 people with myelodysplastic syndrome (MDS) at moderate to very high risk. The first part finds the safest dose of pacritinib, and the second part checks how well the combo works. Researchers will also …
Matched conditions: MYELODYSPLASTIC SYNDROMES
Phase: PHASE1, PHASE2 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated May 17, 2026 03:18 UTC
-
New hope for rare genetic blood cancer: interferon after transplant may cut relapse risk
Disease control Not yet recruitingThis study tests whether the drug interferon-α can help prevent cancer from coming back in people with a specific genetic mutation (TP53) in acute myeloid leukemia or myelodysplastic syndromes. All participants have already had a stem cell transplant and show no signs of cancer. …
Matched conditions: MYELODYSPLASTIC SYNDROMES
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Can patients safely stop Anti-Rejection drugs sooner after transplant?
Disease control Not yet recruitingThis study tests whether patients who receive a stem cell transplant for blood cancers can safely stop taking the immune-suppressing drug tacrolimus earlier than usual. The goal is to reduce side effects while still preventing graft-versus-host disease (GVHD), a common complicati…
Matched conditions: MYELODYSPLASTIC SYNDROMES
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated May 05, 2026 11:56 UTC
-
Can music and mindfulness ease the toll of stem cell transplants?
Symptom relief Not yet recruitingThis study tests an online program that combines mindfulness and music therapy to help people undergoing stem cell transplants feel better and have fewer symptoms. About 165 adults with blood cancers like leukemia or lymphoma will take part. The goal is to see if this approach im…
Matched conditions: MYELODYSPLASTIC SYNDROMES
Phase: NA • Sponsor: University of Miami • Aim: Symptom relief
Last updated May 17, 2026 03:19 UTC
-
5,000 patients to help unravel Immune-Blood link
Knowledge-focused Not yet recruitingThis study will follow 5,000 adults with immune system issues to see how often they also have clonal hematopoiesis (a type of blood cell change) or related blood diseases like VEXAS syndrome. Researchers will track new cases over time to better understand these conditions. No tre…
Matched conditions: MYELODYSPLASTIC SYNDROMES
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 04, 2026 16:23 UTC